Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Conference Paper uri icon

Overview

abstract

  • Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify all relevant articles published between 2009 and 2018. An expert panel screened, reviewed, and graded the studies and formulated the updated consensus recommendations based on the new data. The final document provides consensus recommendations on the diagnosis and management of ITP in adults, during pregnancy, and in children, as well as quality-of-life considerations.

authors

  • Provan, Drew
  • Arnold, Donald M
  • Bussel, James B
  • Chong, Beng H
  • Cooper, Nichola
  • Gernsheimer, Terry
  • Ghanima, Waleed
  • Godeau, Bertrand
  • González-López, Tomás José
  • Grainger, John
  • Hou, Ming
  • Kruse, Caroline
  • McDonald, Vickie
  • Michel, Marc
  • Newland, Adrian C
  • Pavord, Sue
  • Rodeghiero, Francesco
  • Scully, Marie
  • Tomiyama, Yoshiaki
  • Wong, Raymond S
  • Zaja, Francesco
  • Kuter, David J

publication date

  • November 26, 2019

Research

keywords

  • Purpura, Thrombocytopenic, Idiopathic

Identity

PubMed Central ID

  • PMC6880896

Scopus Document Identifier

  • 85076363753

Digital Object Identifier (DOI)

  • 10.1182/bloodadvances.2019000812

PubMed ID

  • 31770441

Additional Document Info

volume

  • 3

issue

  • 22